FDA Fast Track Designation Sends Biotech Soaring Mid-Week - The Globe and Mail

Retrieved on: 2025-02-12 22:59:56

Tags for this article:

Click the tags to see associated articles and topics

FDA Fast Track Designation Sends Biotech Soaring Mid-Week - The Globe and Mail. View article details on hiswai:

Summary

The article discusses NKGen Biotech Inc.'s stock surge following FDA fast track approval for Troculeucel, a treatment for Alzheimer’s. The micro-cap company develops therapies for neurodegenerative diseases, aligning with the 'Alzheimer' key concept and related tags.

Article found on: www.theglobeandmail.com

View Original Article